111 related articles for article (PubMed ID: 3879232)
1. [Analgesic effect of topically applied pranoprofen-gel].
Terasawa M; Yakushiji T; Iwahisa Y; Imayoshi T; Maruyama Y
Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):433-40. PubMed ID: 3879232
[TBL] [Abstract][Full Text] [Related]
2. [Anti-inflammatory effect of topically applied pranoprofen-gel].
Terasawa M; Imayoshi T; Iwahisa Y; Maruyama Y
Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):283-96. PubMed ID: 3874127
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of pranoprofen gel for percutaneous administration.
Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
[TBL] [Abstract][Full Text] [Related]
4. [Effect of pranoprofen on sodium urate crystal-induced inflammation].
Terasawa M; Aratani H; Iwahisa Y; Imayoshi T; Maruyama Y
Nihon Yakurigaku Zasshi; 1987 Mar; 89(3):129-37. PubMed ID: 3583135
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of the inhibitory effect of pranoprofen on sodium urate crystal-induced inflammation].
Aratani H; Iwahisa Y; Imayoshi T; Nagaoka Y; Terasawa M; Maruyama Y
Nihon Yakurigaku Zasshi; 1987 Mar; 89(3):139-44. PubMed ID: 3556352
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
Shin SC; Cho CW
Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
[TBL] [Abstract][Full Text] [Related]
9. [Effects of CN-100 on the functions of rat polymorphonuclear leukocytes].
Yoneta T; Kato H; Yoshida A; Ozeki M; Tagashira E
Nihon Yakurigaku Zasshi; 1991 Jan; 97(1):23-30. PubMed ID: 1646145
[TBL] [Abstract][Full Text] [Related]
10. [Anti-inflammatory and analgesic activities of a trans-cutaneous non-steroidal anti-inflammatory agent, etofenamate gel].
Nakamura H; Yokoyama Y; Motoyoshi S; Seto Y; Ishii K; Imazu C; Kadokawa T; Shimizu M
Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):183-94. PubMed ID: 7173741
[TBL] [Abstract][Full Text] [Related]
11. Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery.
Mishra R; Prabhavalkar KS; Bhatt LK
J Liposome Res; 2016 Dec; 26(4):297-306. PubMed ID: 26785055
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Garduño ML; Garcia ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):350-61. PubMed ID: 26844786
[TBL] [Abstract][Full Text] [Related]
13. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs.
Okuyama S; Aihara H
Jpn J Pharmacol; 1984 Jun; 35(2):95-103. PubMed ID: 6146738
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective acyl glucuronidation and glucosidation of pranoprofen, a 2-arylpropionic acid derivative, in mice in vivo.
Arima N
J Pharmacobiodyn; 1990 Dec; 13(12):733-8. PubMed ID: 2098546
[TBL] [Abstract][Full Text] [Related]
15. Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy.
An SH; Kwon YH
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1489-1496. PubMed ID: 26553195
[TBL] [Abstract][Full Text] [Related]
16. The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes.
Liu X; Wang S; Kao AA; Long Q
Cornea; 2012 Nov; 31(11):1235-9. PubMed ID: 22677643
[TBL] [Abstract][Full Text] [Related]
17. Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain.
Rincón M; Calpena AC; Clares B; Espina M; Garduño-Ramírez ML; Rodríguez-Lagunas MJ; García ML; Abrego G
Nanomedicine (Lond); 2018 Oct; 13(19):2397-2413. PubMed ID: 30311846
[TBL] [Abstract][Full Text] [Related]
18. Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis.
Yassin NZ; El-Shenawy SM; Abdel-Rahman RF; Yakoot M; Hassan M; Helmy S
Drug Des Devel Ther; 2015; 9():1491-8. PubMed ID: 25792809
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
[TBL] [Abstract][Full Text] [Related]
20. Species differences in absorption, metabolism and excretion of pranoprofen, a 2-arylpropionic acid derivative, in experimental animals.
Arima N; Kato Y
J Pharmacobiodyn; 1990 Dec; 13(12):739-44. PubMed ID: 2098547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
